49
Views
38
CrossRef citations to date
0
Altmetric
Research Article

Angioimmunoblastic Lymphadenopathy (AILD) May Respond to Thalidomide Treatment: Two Case Reports

, , , &
Pages 133-137 | Published online: 01 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Fernando Roncolato, Anna Gazzola, Pier Luigi Zinzani, Stefano A Pileri & Pier Paolo Piccaluga. (2011) Targeted molecular therapy in peripheral T-cell lymphomas. Expert Review of Hematology 4:5, pages 551-562.
Read now
Rebecca A Howman & H Miles Prince. (2011) New drug therapies in peripheral T-cell lymphoma. Expert Review of Anticancer Therapy 11:3, pages 457-472.
Read now
Jennifer E. Amengual & Bruce G. Raphael. (2010) Sustained, durable responses with alemtuzumab in refractory angioimmunoblastic T-cell lymphoma. Leukemia & Lymphoma 51:7, pages 1347-1350.
Read now
Fadi Braiteh, Ankur Parikh & Peter McLaughlin. (2009) A suspicion of chikungunya leading to a diagnosis of angioimmunoblastic T-cell lymphoma. Acta Oncologica 48:4, pages 624-628.
Read now
Michele Gottardi, Cristina Danesin, Fabio Canal, Angelo Paolo Dei Tos, Piero Maria Stefani, Elisabetta Calistri, Ugo Salvadori & Filippo Gherlinzoni. (2008) Complete remission induced by thalidomide in a case of angioimmunoblastic T-cell lymphoma refractory to autologous stem cell transplantation. Leukemia & Lymphoma 49:9, pages 1836-1838.
Read now
Barbara Pro & Peter McLaughlin. (2007) Angioimmunoblastic T-Cell Lymphoma: Still a dismal prognosis with current treatment approaches. Leukemia & Lymphoma 48:4, pages 645-646.
Read now

Articles from other publishers (32)

. Experimental and Clinical Transplantation 16:3.
Crossref
Pier Paolo Piccaluga, Mohsen Navari, Maryam Etebari & Stefano A Pileri. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences 1 9 .
HONGYANG WU, CHENCHEN ZHAO, KANGSHENG GU, YANG JIAO, JIQING HAO & GUOPING SUN. (2014) Thalidomide plus chemotherapy exhibit enhanced efficacy in the clinical treatment of T-cell non-Hodgkin’s lymphoma: A prospective study of 46 cases. Molecular and Clinical Oncology 2:5, pages 695-700.
Crossref
Pier Paolo Piccaluga, Valentina Tabanelli & Stefano A. Pileri. (2014) Molecular genetics of peripheral T-cell lymphomas. International Journal of Hematology 99:3, pages 219-226.
Crossref
Andrew Lipsky, Patricia Pérez-Galán, Claudio Agostinelli, Pier Paolo Piccaluga, Stefano A. Pileri & Adrian Wiestner. 2014. Rare Lymphomas. Rare Lymphomas 71 95 .
Domenico Ribatti, Beatrice Nico, Girolamo Ranieri, Giorgina Specchia & Angelo Vacca. (2013) The Role of Angiogenesis in Human Non-Hodgkin Lymphomas. Neoplasia 15:3, pages 231-238.
Crossref
Pier Paolo Piccaluga & Stefano A. Pileri. 2013. Lymphoma. Lymphoma 53 63 .
Pier Paolo Piccaluga & Stefano Aldo Pileri. 2013. T-Cell Lymphomas. T-Cell Lymphomas 41 56 .
Stefano A. Pileri & Pier Paolo Piccaluga. (2012) New molecular insights into peripheral T cell lymphomas. Journal of Clinical Investigation 122:10, pages 3448-3455.
Crossref
Claire E. Dearden, Rod Johnson, Ruth Pettengell, Stephen Devereux, Kate Cwynarski, Sean Whittaker & Andrew McMillan. (2011) Guidelines for the management of mature T‐cell and NK‐cell neoplasms (excluding cutaneous T‐cell lymphoma). British Journal of Haematology 153:4, pages 451-485.
Crossref
Laurence De Leval, Christian Gisselbrecht & Philippe Gaulard. (2010) Advances in the understanding and management of angioimmunoblastic T‐cell lymphoma. British Journal of Haematology 148:5, pages 673-689.
Crossref
Michael Medinger, Natalie Fischer & Alexandar Tzankov. (2010) Vascular Endothelial Growth Factor-Related Pathways in Hemato-Lymphoid Malignancies. Journal of Oncology 2010, pages 1-13.
Crossref
J. Rodríguez, A. Gutiérrez, B. Martínez-Delgado & G. Perez-Manga. (2009) Current and future aggressive peripheral T-cell lymphoma treatment paradigms, biological features and therapeutic molecular targets. Critical Reviews in Oncology/Hematology 71:3, pages 181-198.
Crossref
Charalampia KyriakouCarmen CanalsJürgen FinkeGuido KobbeJean-Luc HarousseauHans-Jochem KolbNicolas NovitzkyAnthony H. GoldstoneAnna SuredaNorbert Schmitz. (2009) Allogeneic Stem Cell Transplantation Is Able to Induce Long-Term Remissions in Angioimmunoblastic T-Cell Lymphoma: A Retrospective Study From the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology 27:24, pages 3951-3958.
Crossref
Klio Konstantinou, Kouhei Yamamoto, Fumiaki Ishibashi, Yuiko Mizoguchi, Morito Kurata, Yasunori Nakagawa, Kenshi Suzuki, Motoji Sawabe, Masatsugu Ohta, Shigesaburo Miyakoshi, James T. Crawley & Masanobu Kitagawa. (2009) Angiogenic mediators of the angiopoietin system are highly expressed by CD10-positive lymphoma cells in angioimmunoblastic T-cell lymphoma. British Journal of Haematology 144:5, pages 696-704.
Crossref
Emilio Iannitto, Andrés J.M. Ferreri, Viviana Minardi, Claudio Tripodo & Hans H. Kreipe. (2008) Angioimmunoblastic T-cell lymphoma. Critical Reviews in Oncology/Hematology 68:3, pages 264-271.
Crossref
Charalampia KyriakouCarmen CanalsAnthony GoldstoneDolores CaballeroBernd MetznerGuido KobbeHans-Jochem KolbJoachim KienastPeter ReimerJurgen FinkeGunnar ObergAnn HunterNiklas TheorinAnna SuredaNorbert Schmitz. (2008) High-Dose Therapy and Autologous Stem-Cell Transplantation in Angioimmunoblastic Lymphoma: Complete Remission at Transplantation Is the Major Determinant of Outcome—Lymphoma Working Party of the European Group for Blood and Marrow Transplantation. Journal of Clinical Oncology 26:2, pages 218-224.
Crossref
Delvys Rodriguez‐Abreu, Volmar Belisario Filho & Emanuele Zucca. (2007) Peripheral T‐cell lymphomas, unspecified (or not otherwise specified): a review. Hematological Oncology 26:1, pages 8-20.
Crossref
Pier Paolo Piccaluga, Claudio Agostinelli, Andrea Califano, Antonino Carbone, Luca Fantoni, Sergio Ferrari, Anna Gazzola, Annunziata Gloghini, Simona Righi, Maura Rossi, Enrico Tagliafico, Pier Luigi Zinzani, Simonetta Zupo, Michele Baccarani & Stefano A. Pileri. (2007) Gene Expression Analysis of Angioimmunoblastic Lymphoma Indicates Derivation from T Follicular Helper Cells and Vascular Endothelial Growth Factor Deregulation. Cancer Research 67:22, pages 10703-10710.
Crossref
Florence Lachenal. (2007) Lymphomes T angio-immunoblastiques. La Presse Médicale 36:11, pages 1655-1662.
Crossref
Yuanping Zhou, Ayoma D. Attygalle, Shih-Sung Chuang, Tim Diss, Hongtao Ye, Hongxiang Liu, Rifat A. Hamoudi, Philippa Munson, Chris M. Bacon, Ahmet Dogan & Ming-Qing Du. (2007) Angioimmunoblastic T-cell lymphoma: histological progression associates with EBV and HHV6B viral load. British Journal of Haematology 138:1, pages 44-53.
Crossref
José Rodríguez, Eulogio Conde, Antonio Gutiérrez, Reyes Arranz, Marcos Gandarillas, Angel Leon, Jesus Ojanguren, Anna Sureda, Dolores Carrera, Mauricio Bendandi, Jose Moraleda, Jose Maria Ribera, Carmen Albo, Alfonso Morales, Juan Carlos García, Pascual Fernández, Guillermo Cañigral, Juan Bergua & María Dolores Caballero. (2007) Prolonged survival of patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation. The GELTAMO experience. European Journal of Haematology 78:4, pages 290-296.
Crossref
Anu G. Jayaraman, David Cassarino, Ranjana Advani, Youn H. Kim, Eunice Tsai & Sabine Kohler. (2006) Cutaneous involvement by angioimmunoblastic T-cell lymphoma: a unique histologic presentation, mimicking an infectious etiology. Journal of Cutaneous Pathology 33:s2, pages 6-11.
Crossref
Stephanie Halene, Arthur Zieske & Nancy Berliner. (2006) Sustained remission from angioimmunoblastic T-cell lymphoma induced by alemtuzumab. Nature Clinical Practice Oncology 3:3, pages 165-168.
Crossref
Ad Koster & John M.M Raemaekers. (2005) Angiogenesis in malignant lymphoma. Current Opinion in Oncology 17:6, pages 611-616.
Crossref
C. Strupp, R. Fenk, A. Kündgen, N. Gattermann, R. Haas & U. Germing. (2005) Hairy cell leukemia (HCL) with extensive myelofibrosis responds to thalidomide. Leukemia Research 29:8, pages 967-969.
Crossref
A Dogan, L S P Ngu, S H Ng & P L Cervi. (2005) Pathology and clinical features of angioimmunoblastic T-cell lymphoma after successful treatment with thalidomide. Leukemia 19:5, pages 873-875.
Crossref
Domenico RibattiClaudio ScavelliAldo M. RoccaroEnrico CrivellatoBeatrice NicoAngelo Vacca. (2004) Hematopoietic Cancer and Angiogenesis. Stem Cells and Development 13:5, pages 484-495.
Crossref
Shaji Kumar, Thomas E. Witzig & S. Vincent Rajkumar. (2004) Thalidomide: Current Role in the Treatment of Non-Plasma Cell Malignancies. Journal of Clinical Oncology 22:12, pages 2477-2488.
Crossref
C. Strupp, U. Germing, A. Scherer, A. Kündgen, U. Mödder, N. Gattermann & R. Haas. (2004) Thalidomide for the treatment of idiopathic myelofibrosis. European Journal of Haematology 72:1, pages 52-57.
Crossref
D.V. Kazakov, T. Mentzel, G. Burg, R. Dummer & W. Kempf. (2003) Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more?. British Journal of Dermatology 149:4, pages 869-876.
Crossref
Ahmet Dogan, Ayoma D. Attygalle & Chara Kyriakou. (2003) Angioimmunoblastic T-cell lymphoma. British Journal of Haematology 121:5, pages 681-691.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.